Login to Your Account



Other news to note


Friday, July 25, 2014
Cipher Pharmaceuticals Inc., of Mississauga, Ontario, said it entered a definitive distribution and supply agreement granting Ranbaxy Laboratories Ltd., of Mumbai, India, the exclusive right to market, sell and distribute Cipher's isotretinoin capsules in Brazil.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription